The highest resolution, and only true 3D, transmission ultrasound technology that uses biomarkers for the early detection of breast cancer.
The National Cancer Institute, part of The National Institutes of Health (NIH) has awarded grants of over $15 million to fund the continued development of this technology and our clinical trials.
QT Ultrasound has received FDA 510(k) clearance for diagnostic imaging of breast health, as an adjunct to mammography. At this time, it is not intended to be used as a replacement for screening mammography.
Dense breasts are common. In fact, over half of all women have dense breasts. With images that show clear information about breast tissue, our goal is to identify what is benign, and what’s problematic.
For every 1 woman
who is diagnosed
with breast cancer
19 will have
when nothing is wrong
are false positives
We hope to change that. (Source: SBI)
* Source: Mark Lenox et al. Imaging Performance of Quantitative Transmission Ultrasound, International Journal of Biomedical Imaging
B. Malik, R. Terry, and M. Lenox, Quantitative Transmission Ultrasound Tomography: Imaging and Performance Characteristics, Medical Physics, in review.